Skip to main content
Mauna Kea Technologies logo

Mauna Kea Technologies — Investor Relations & Filings

Ticker · MKEA ISIN · FR0010609263 LEI · 5493007KMDG4MFIGJJ63 PA Manufacturing
Open in API
Filings indexed 780 across all filing types
Latest filing 2014-05-15 Major Shareholding Noti…
Country FR France
Listing PA MKEA

About Mauna Kea Technologies

https://www.maunakeatech.com/en/

Mauna Kea Technologies is a medical device company that develops and markets the Cellvizio® platform, a real-time in vivo cellular imaging system. The platform utilizes Confocal Laser Endomicroscopy (CLE) technology, enabling physicians to visualize tissue at the cellular level during medical procedures. This "optical biopsy" is performed using flexible, miniature fiber-optic probes (Confocal Miniprobes™) that are compatible with standard endoscopes. The core function of Cellvizio® is to provide immediate microscopic visualization, which aids in accelerating diagnosis, informing treatment strategies, and improving the precision of therapeutic interventions. Key applications include gastroenterology (for conditions such as Barrett's esophagus and pancreatic cysts), interventional pulmonology (lung cancer diagnostics), urologic oncology, and neurosurgery. The technology supports enhanced surgical procedures, including real-time margin assessment, and is being integrated with robotic surgery and AI-assisted imaging systems.

Recent filings

Filing Released Lang Actions
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Major Shareholding Notification Classification · 99% confidence The document is a press release dated May 15, 2014, announcing that a major shareholder (CREADEV) has crossed below the 3% ownership threshold by selling shares to new investors. This action triggers mandatory disclosure requirements regarding changes in significant share ownership. The core subject is the notification of a change in a significant shareholding level, which directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is a press release, its primary informational content is the shareholding change, making MRQ more specific than a general Regulatory Filing (RNS) or Report Publication Announcement (RPA). The document length is short (2983 chars), but it contains the substantive information rather than just announcing an attached report.
2014-05-15 French
Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change Classification · 95% confidence The document is titled "Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social" (Monthly information relating to the total number of voting rights and shares comprising the share capital). It explicitly references the French Commercial Code (Article L233-8-II) and the General Regulation of the AMF (Autorité des Marchés Financiers). It provides a table detailing the number of shares and total voting rights as of April 30, 2014. This content directly relates to the official disclosure of voting rights and share capital structure, which falls under the scope of regulatory reporting concerning ownership and capital structure, but it is not a standard SEC filing like 10-K or a general announcement like RNS. Given the specific nature of reporting voting rights and capital structure changes, it is best classified as a regulatory filing that doesn't fit the other specific categories. However, since the document is a direct disclosure of capital structure information (shares and voting rights), and not an announcement *about* a report, it is a specific regulatory disclosure. Among the provided codes, 'SHA' (Share Issue/Capital Change) is the closest fit as it deals with the composition of the capital and voting rights, although 'RNS' (Regulatory Filings) is a strong fallback. Since the core content is the monthly update on the total number of shares and voting rights, which is a fundamental aspect of capital structure reporting, SHA is the most precise fit among the specific options, as it relates to the capital composition.
2014-05-12 French
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings Classification · 85% confidence The document is a press release from Mauna Kea Technologies announcing the presentation of research abstracts involving their Cellvizio product at the Digestive Disease Week (DDW) 2014 conference. It details scientific findings, educational courses, and provides general company information. This type of announcement, focusing on scientific/research updates and participation in industry events, does not fit neatly into the specific financial filing categories like 10-K, ER, or IR. It is a general corporate communication. Since it is not a formal regulatory filing (like a 10-K or 8-K), nor a specific report (like an Audit Report or Interim Report), and it is not a transcript, presentation, or management discussion, the most appropriate fallback category is Regulatory Filings (RNS) for general corporate news that doesn't fit elsewhere, although it is essentially a press release about scientific progress.
2014-05-06 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release dated May 6, 2014, announcing that Mauna Kea Technologies presented 43 studies related to its Cellvizio product at the Digestive Disease Week (DDW) 2014 conference. It details the research presented, workshops held, and provides background information on DDW and the company. This type of announcement, detailing participation in a scientific/industry event and the presentation of research findings, is typically classified as a general corporate announcement or a regulatory filing if it contains material, non-public information intended for broad dissemination. Since it is not a formal financial report (10-K, IR, ER, MRQ), nor a specific management/board change, nor a dividend notice, it fits best under the general 'Regulatory Filings' (RNS) category as a broad corporate communication, or potentially an Investor Presentation (IP) if it were the presentation itself, but this is an announcement *about* presentations. Given the options, RNS serves as the best general regulatory/corporate announcement fallback for non-standard financial disclosures.
2014-05-06 French
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release dated April 28, 2014, announcing that Mauna Kea Technologies has obtained regulatory authorization (Class 1 and Class 2 NINSHO) from the Japanese Ministry of Health, Labour and Welfare (MHLW) for its Cellvizio product. This type of announcement, detailing a significant business event (regulatory approval in a key market) but not being a formal periodic financial report (like 10-K or IR), typically falls under general corporate news or regulatory updates. Since it is a specific announcement about a business development rather than a general regulatory filing fallback (RNS), and it is not a management discussion, earnings release, or capital event, it is best classified as a general Regulatory Filing (RNS) as it pertains to official market clearance, or potentially a general announcement. Given the options, RNS serves as the best fit for specific, non-standard corporate news releases that aren't covered by the other specific codes (like ER, CAP, DIV). However, since it is a major business development announcement, and not a standard regulatory form filing, RNS is the most appropriate catch-all for significant, non-financial periodic news.
2014-04-28 French
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings Classification · 95% confidence The document is a press release dated April 28, 2014, announcing that Mauna Kea Technologies received regulatory approval (Class 1 authorization and Class 2 NINSHO approval) from Japan's Ministry of Health, Labor and Welfare (MHLW) for its Cellvizio product. This is a specific, non-periodic corporate announcement regarding a regulatory milestone and market expansion, not a standard financial filing like a 10-K, IR, or ER. It does not fit the definitions for AGM-R, 10-K, AR, MANG, CT, CAP, DVA, DLST, DIRS, ER, SR, XLSX, FS, CGR, IRAT, IR, IP, LTR, TAR, MRQ, MDA, NAV, DIV, PSI, DEF 14A, RPA, SHA, or POS. Since it is a specific regulatory/market announcement that doesn't fit the primary categories, the most appropriate fallback is Regulatory Filings (RNS), as it is a general regulatory update/announcement.
2014-04-28 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.